By Dr Claire Lancaster Fifty million people live with dementia worldwide, the most common cause of which is Alzheimer’s – a progressive, neurodegenerative disease. Although the past 12-months have seen Aducanumab expediated for FDA approval – the first new drug…
Most popular posts coming soon